Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
7
pubmed:dateCreated
1997-11-13
pubmed:abstractText
Recent studies have shown that the brain is not a barrier to successful active immunotherapy that uses gene-modified autologous tumor cell vaccines. In this study, we compared the efficacy of two types of vaccines for the treatment of tumors within the central nervous system (CNS): dendritic cell (DC)-based vaccines pulsed with either tumor extract or tumor RNA, and cytokine gene-modified tumor vaccines. Using the B16/F10 murine melanoma (B16) as a model for CNS tumor, we show that vaccination with bone marrow-generated DCs, pulsed with either B16 cell extract or B16 total RNA, can induce specific cytotoxic T lymphocytes against B16 tumor cells. Both types of DC vaccines were able to protect animals from tumors located in the CNS. DC-based vaccines also led to prolonged survival in mice with tumors placed before the initiation of vaccine therapy. The DC-based vaccines were at least as effective, if not more so, as vaccines containing B16 tumor cells in which the granulocytic macrophage colony-stimulating factor gene had been modified. These data support the use of DC-based vaccines for the treatment of patients with CNS tumors.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/9314567-1109790, http://linkedlifedata.com/resource/pubmed/commentcorrection/9314567-1460426, http://linkedlifedata.com/resource/pubmed/commentcorrection/9314567-2809683, http://linkedlifedata.com/resource/pubmed/commentcorrection/9314567-325299, http://linkedlifedata.com/resource/pubmed/commentcorrection/9314567-3872167, http://linkedlifedata.com/resource/pubmed/commentcorrection/9314567-6165811, http://linkedlifedata.com/resource/pubmed/commentcorrection/9314567-7435141, http://linkedlifedata.com/resource/pubmed/commentcorrection/9314567-7540653, http://linkedlifedata.com/resource/pubmed/commentcorrection/9314567-7703440, http://linkedlifedata.com/resource/pubmed/commentcorrection/9314567-8011285, http://linkedlifedata.com/resource/pubmed/commentcorrection/9314567-8097319, http://linkedlifedata.com/resource/pubmed/commentcorrection/9314567-8161884, http://linkedlifedata.com/resource/pubmed/commentcorrection/9314567-8551233, http://linkedlifedata.com/resource/pubmed/commentcorrection/9314567-8551239, http://linkedlifedata.com/resource/pubmed/commentcorrection/9314567-8551248, http://linkedlifedata.com/resource/pubmed/commentcorrection/9314567-8609412, http://linkedlifedata.com/resource/pubmed/commentcorrection/9314567-8610141, http://linkedlifedata.com/resource/pubmed/commentcorrection/9314567-8760800, http://linkedlifedata.com/resource/pubmed/commentcorrection/9314567-8816812, http://linkedlifedata.com/resource/pubmed/commentcorrection/9314567-9079797, http://linkedlifedata.com/resource/pubmed/commentcorrection/9314567-9096653
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
0022-1007
pubmed:author
pubmed:issnType
Print
pubmed:day
6
pubmed:volume
186
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1177-82
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
1997
pubmed:articleTitle
Bone marrow-generated dendritic cells pulsed with tumor extracts or tumor RNA induce antitumor immunity against central nervous system tumors.
pubmed:affiliation
Department of Pediatrics, Duke University Medical Center, Durham, North Carolina 27710, USA.
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S., Research Support, Non-U.S. Gov't